| 2025 | 2024 | 2023 | 2022 | 2021 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,1 M € | +16.8% | 3,5 M € | +0.1% | 3,5 M € | -2.2% | 3,6 M € | +7.5% | 3,3 M € | +5.3% | 3,2 M € | +9.9% | 2,9 M € | +7.6% | 2,7 M € | +5.4% | 2,6 M € | +5.9% | 2,4 M € | -1.0% | 2,4 M € | +0.6% | 2,4 M € | |
| EBITDA | 645,0 k € | +43.4% | 449,9 k € | +2.5% | 438,8 k € | +138.0% | 184,3 k € | -31.6% | 269,3 k € | +125.8% | 119,3 k € | -40.3% | 199,7 k € | +743.2% | 23,7 k € | -69.6% | 78,0 k € | +436.4% | 14,5 k € | -94.1% | 245,3 k € | -7.5% | 265,2 k € | |
| Operating profit | 636,2 k € | +34.7% | 472,2 k € | +10.8% | 426,3 k € | +170.8% | 157,4 k € | -45.1% | 286,7 k € | +177.5% | 103,3 k € | -46.2% | 192,0 k € | +1735.9% | 10,5 k € | -83.9% | 64,8 k € | +6371.7% | 1,0 k € | -99.6% | 236,2 k € | -9.5% | 260,9 k € | |
| Profit/loss | 473,8 k € | +33.9% | 353,9 k € | +13.3% | 312,4 k € | +177.6% | 112,5 k € | -46.2% | 209,1 k € | +174.9% | 76,1 k € | -48.1% | 146,5 k € | +511.3% | 24,0 k € | -61.6% | 62,4 k € | +48928.0% | 127,3 € | -99.9% | 150,8 k € | -11.8% | 171,0 k € | |
| Equity | 669,2 k € | +12.4% | 595,4 k € | +21.1% | 491,5 k € | +29.6% | 379,1 k € | +3.4% | 366,6 k € | -35.2% | 565,9 k € | -4.1% | 589,9 k € | -30.1% | 843,3 k € | +2.9% | 819,4 k € | +8.2% | 757,0 k € | +0.0% | 756,8 k € | +24.9% | 606,0 k € | |
| Total assets | 1,7 M € | +16.0% | 1,5 M € | +9.9% | 1,3 M € | -4.8% | 1,4 M € | +31.5% | 1,1 M € | -37.7% | 1,7 M € | -12.7% | 1,9 M € | +4.6% | 1,9 M € | +11.2% | 1,7 M € | -23.4% | 2,2 M € | -6.0% | 2,3 M € | +4.3% | 2,2 M € | |
| Cash | — | — | — | — | — | 27,9 k € | -12.4% | 31,9 k € | -49.0% | 62,5 k € | +154.7% | 24,5 k € | +11582.8% | 210,1 € | -99.8% | 105,4 k € | -57.3% | 246,6 k € | ||||||
| Debts | 1,0 M € | +18.7% | 854,6 k € | +3.2% | 828,4 k € | -17.7% | 1,0 M € | +48.9% | 675,9 k € | -20.5% | 850,5 k € | -20.4% | 1,1 M € | +48.2% | 720,5 k € | +30.9% | 550,5 k € | -43.6% | 975,8 k € | -10.2% | 1,1 M € | +16.1% | 935,7 k € | |
| Staff | 8,8 | 8,9 | 11,8 | 13,9 | 14,7 | 35,6 | 31,8 | 34,9 | 31,7 | 31,6 | 29,1 | 26,8 | ||||||||||||
Public limited company · Turnhout · incorporated on 27/11/2002 · 8,8 ETP
Public limited company profitable and well capitalised. Cash position declining (-12.4%).
Solid counterparty for a standard engagement.
VAN ROOIJEN PHARMA is a Public limited company incorporated in 2002. Its main activity is: Warehousing and storage. Its registered office is in Turnhout. It employs on average 8,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette